1) JNK1 mRNA
c-Jun氨基末端蛋白激酶
2) Stressactivated protein kinase/c-Jun NH_2-terminal kinase
应激活化蛋白激酶/c-Jun氨基末端激酶
3) protein kinases/c-jun NH_2 terminal protein kinase
蛋白激酶类/c-Jun氨基末端激酶
4) JNK
c-jun氨基末端激酶
1.
Objective:To study the action mechanism of p,p'-DDE and /or β-BHC on JNK and MAPK signal transduction pathways in rat Sertoli cells in vitro.
目的:研究2,2-双-(对氯苯基)-1,1-二氯乙烯(p,p'-DDE)和β-六氯化苯(β-BHC)单独作用及联合作用对离体培养大鼠睾丸Sertoli细胞c-jun氨基末端激酶(JNK)丝裂原活化蛋白激酶(MAPK)信号转导通路的作用机制。
2.
However, it remains largely controversial whether c-Jun NH2- terminal kinase (JNK) is involved in the effects of insulin on MI/R injury.
然而c-Jun氨基末端激酶(c-Jun NH2-terminal kinase,JNK)信号通路在胰岛素保护I/R心肌中的作用尚不清楚,本研究旨在探讨JNK信号通路在胰岛素保护I/R心肌中的作用及其与PI3-K/Akt信号通路间的相互关系。
3.
Objective:To study the action mechanism of p,p -DDE and /or β-BHC on JNK and MAPK signal transduction pathways in rat Sertoli cells in vitro.
目的:研究2,2-双-(对氯苯基)-1,1-二氯乙烯(p,p'-DDE)和β-六氯化苯(β-BHC)单独作用及联合作用对离体培养大鼠睾丸Sertoli细胞c-jun氨基末端激酶(JNK)丝裂原活化蛋白激酶(MAPK)信号转导通路的作用机制。
5) c-Jun N-terminal kinase
c-Jun氨基末端激酶
1.
Role of c-Jun N-terminal kinase in the regulation of TGF-β_1-induced fibronectin production in rat mesangial cells;
c-Jun氨基末端激酶在转化生长因子-β_1诱导肾系膜细胞合成纤维连接蛋白中的作用
2.
Expression and significance of c-Jun N-terminal kinase (JNK) in the rat of nonalcoholic fatty liver disease with insulin resistance
c-jun氨基末端激酶在非酒精性脂肪肝病胰岛素抵抗大鼠中的表达及意义
3.
Objective:To study the expression of phosphorylated c-Jun N-terminal kinase (P-JNK) in lung tissues,the amounts of IL-1β in serum and BALF of asthmatic rats of airway remodeling,whereby to explore the role of P-JNK in asthma airway remodeling and the possible effect of IL-1β on JNK activation.
目的:研究哮喘气道重塑大鼠肺组织磷酸化c-Jun氨基末端激酶(P-JNK)的表达,血清/支气管肺泡灌洗液(BALF)白介素1β(IL-1β)的含量,探讨P-JNK在哮喘气道重塑中的作用及IL-1β对JNK活化的可能影响。
6) C-jun N-terminal kinase(JNK)
C-jun氨基末端激酶
1.
Objective To explore the role of c-Jun N-terminal kinase(JNK)in the apoptosis induced by apoptin gene in human melanoma cell A375.
目的研究肿瘤特异性凋亡基因(Apoptin gene)在诱导人黑色素瘤细胞A375发生凋亡时,c-Jun氨基末端激酶(JNK)信号通路在细胞发生凋亡中的作用。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条